Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy

R M Knott, M M Pascal, C Ferguson, J Leiper, John Olson, Elizabeth Muckersie, Marie Robertson, John Vincent Forrester

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In the present study, we examined the effect of glucose concentration on the expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor-beta (TGF-beta) mRNA using reverse transcriptase-polymerase chain reaction (RT-PCR) in normal healthy leukocytes in vitro and in leukocytes from patients with type 1 diabetes mellitus. In vitro, the level of TGF-beta mRNA was altered in response to the glucose concentration (maximum at 10 mmol/L), while bFGF mRNA remained relatively constant and VEGF mRNA varied with no clear correlation with the glucose concentration. Leukocytes from type 1 patients showed no difference in bFGF or TGF-beta mRNA levels compared with age-matched healthy controls. However, VEGF mRNA was significantly lower in type 1 patients compared with controls (P < .05). When the patients were subtyped according to the severity of retinopathy, the level of TGF-beta mRNA was elevated selectively in patients with evidence of active new retinal vessels (P < .01) and VEGF(121) mRNA was reduced in patients with mild to moderate retinopathy. Thus, leukocyte growth factor mRNAs respond to acute changes in the glucose concentration in vitro, and are differentially expressed in type 1 diabetic patients during the course of the disease. Copyright(C) 1999 by W.B. Saunders Company.

Original languageEnglish
Pages (from-to)1172-1178
Number of pages7
JournalMetabolism
Volume48
Issue number9
DOIs
Publication statusPublished - Sep 1999

Keywords

  • circulating mononuclear cells
  • permeability factor
  • adhesion molecules
  • glucose transport
  • IDDM
  • complications
  • progression
  • expression
  • monocytes
  • rats

Cite this

Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy. / Knott, R M ; Pascal, M M ; Ferguson, C ; Leiper, J ; Olson, John; Muckersie, Elizabeth; Robertson, Marie; Forrester, John Vincent.

In: Metabolism, Vol. 48, No. 9, 09.1999, p. 1172-1178.

Research output: Contribution to journalArticle

Knott, R M ; Pascal, M M ; Ferguson, C ; Leiper, J ; Olson, John ; Muckersie, Elizabeth ; Robertson, Marie ; Forrester, John Vincent. / Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy. In: Metabolism. 1999 ; Vol. 48, No. 9. pp. 1172-1178.
@article{cbe1019113be49a6bda890b2c9674916,
title = "Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy",
abstract = "In the present study, we examined the effect of glucose concentration on the expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor-beta (TGF-beta) mRNA using reverse transcriptase-polymerase chain reaction (RT-PCR) in normal healthy leukocytes in vitro and in leukocytes from patients with type 1 diabetes mellitus. In vitro, the level of TGF-beta mRNA was altered in response to the glucose concentration (maximum at 10 mmol/L), while bFGF mRNA remained relatively constant and VEGF mRNA varied with no clear correlation with the glucose concentration. Leukocytes from type 1 patients showed no difference in bFGF or TGF-beta mRNA levels compared with age-matched healthy controls. However, VEGF mRNA was significantly lower in type 1 patients compared with controls (P < .05). When the patients were subtyped according to the severity of retinopathy, the level of TGF-beta mRNA was elevated selectively in patients with evidence of active new retinal vessels (P < .01) and VEGF(121) mRNA was reduced in patients with mild to moderate retinopathy. Thus, leukocyte growth factor mRNAs respond to acute changes in the glucose concentration in vitro, and are differentially expressed in type 1 diabetic patients during the course of the disease. Copyright(C) 1999 by W.B. Saunders Company.",
keywords = "circulating mononuclear cells, permeability factor, adhesion molecules, glucose transport, IDDM, complications, progression, expression, monocytes, rats",
author = "Knott, {R M} and Pascal, {M M} and C Ferguson and J Leiper and John Olson and Elizabeth Muckersie and Marie Robertson and Forrester, {John Vincent}",
year = "1999",
month = "9",
doi = "10.1016/S0026-0495(99)90134-8",
language = "English",
volume = "48",
pages = "1172--1178",
journal = "Metabolism",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy

AU - Knott, R M

AU - Pascal, M M

AU - Ferguson, C

AU - Leiper, J

AU - Olson, John

AU - Muckersie, Elizabeth

AU - Robertson, Marie

AU - Forrester, John Vincent

PY - 1999/9

Y1 - 1999/9

N2 - In the present study, we examined the effect of glucose concentration on the expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor-beta (TGF-beta) mRNA using reverse transcriptase-polymerase chain reaction (RT-PCR) in normal healthy leukocytes in vitro and in leukocytes from patients with type 1 diabetes mellitus. In vitro, the level of TGF-beta mRNA was altered in response to the glucose concentration (maximum at 10 mmol/L), while bFGF mRNA remained relatively constant and VEGF mRNA varied with no clear correlation with the glucose concentration. Leukocytes from type 1 patients showed no difference in bFGF or TGF-beta mRNA levels compared with age-matched healthy controls. However, VEGF mRNA was significantly lower in type 1 patients compared with controls (P < .05). When the patients were subtyped according to the severity of retinopathy, the level of TGF-beta mRNA was elevated selectively in patients with evidence of active new retinal vessels (P < .01) and VEGF(121) mRNA was reduced in patients with mild to moderate retinopathy. Thus, leukocyte growth factor mRNAs respond to acute changes in the glucose concentration in vitro, and are differentially expressed in type 1 diabetic patients during the course of the disease. Copyright(C) 1999 by W.B. Saunders Company.

AB - In the present study, we examined the effect of glucose concentration on the expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor-beta (TGF-beta) mRNA using reverse transcriptase-polymerase chain reaction (RT-PCR) in normal healthy leukocytes in vitro and in leukocytes from patients with type 1 diabetes mellitus. In vitro, the level of TGF-beta mRNA was altered in response to the glucose concentration (maximum at 10 mmol/L), while bFGF mRNA remained relatively constant and VEGF mRNA varied with no clear correlation with the glucose concentration. Leukocytes from type 1 patients showed no difference in bFGF or TGF-beta mRNA levels compared with age-matched healthy controls. However, VEGF mRNA was significantly lower in type 1 patients compared with controls (P < .05). When the patients were subtyped according to the severity of retinopathy, the level of TGF-beta mRNA was elevated selectively in patients with evidence of active new retinal vessels (P < .01) and VEGF(121) mRNA was reduced in patients with mild to moderate retinopathy. Thus, leukocyte growth factor mRNAs respond to acute changes in the glucose concentration in vitro, and are differentially expressed in type 1 diabetic patients during the course of the disease. Copyright(C) 1999 by W.B. Saunders Company.

KW - circulating mononuclear cells

KW - permeability factor

KW - adhesion molecules

KW - glucose transport

KW - IDDM

KW - complications

KW - progression

KW - expression

KW - monocytes

KW - rats

U2 - 10.1016/S0026-0495(99)90134-8

DO - 10.1016/S0026-0495(99)90134-8

M3 - Article

VL - 48

SP - 1172

EP - 1178

JO - Metabolism

JF - Metabolism

SN - 0026-0495

IS - 9

ER -